HALRESPO
Live / Applied — Third extension granted (statement of use) (as of 03 Feb 2026)
What this means for you
Not registered yet, but its 16 Oct 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98225083
- Mark type
- Stylized text
- Filed
- 16 Oct 2023
- Published for opposition
- 09 Jul 2024
- Attorney of record
- David S. Jacobson
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for treating respiratory diseases; Pharmaceutical preparations for the treatment of autoimmune diseases; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical products for treating autoimmune pulmonary diseases and disorders
Owner
- Savara, Inc., Langhorne, PA, US
- Savara, Inc., Langhorne, PA, US
Prosecution history
- 04 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Feb 2026 — SOU EXTENSION 3 GRANTED
- 03 Feb 2026 — SOU EXTENSION 3 FILED
- 03 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 08 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Aug 2025 — SOU EXTENSION 2 GRANTED
- 07 Aug 2025 — SOU EXTENSION 2 FILED
- 07 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 30 Jan 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Jan 2025 — SOU EXTENSION 1 GRANTED
- 29 Jan 2025 — SOU EXTENSION 1 FILED
- 29 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Sept 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 09 Jul 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Jul 2024 — PUBLISHED FOR OPPOSITION